Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AccrelistSGX:QZG +13.11% FCF Margin % is 0.87% as of Mar. 2026, which is 43% below its 10-year median of 1.52. The stock has 6 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Accrelist ranks worse than 57.44% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Accrelist's Free Cash Flow for the
six
months ended in Mar. 2026 was S$0.07 Mil. Accrelist's Revenue for the
six
months ended in Mar. 2026 was S$8.27 Mil. Therefore, Accrelist's FCF Margin % for the quarter that ended in Mar. 2026 was 0.87%.
The historical rank and industry rank for Accrelist's FCF Margin % or its related term are showing as below:
SGX:QZG'
s FCF Margin % Range Over the Past 10 Years
Min: -62 Med: 1.52 Max: 1067.7
Current: 0.82
During the past 13 years, the highest FCF Margin % of Accrelist was 1067.70%. The lowest was -62.00%. And the median was 1.52%.
SGX:QZG's FCF Margin % is ranked worse than 57.44% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 3.15
vs SGX:QZG: 0.82
The historical data trend for Accrelist's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Accrelist's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accrelist FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Accrelist's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Accrelist's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accrelist (SGX:QZG) has a FCF Margin % of 0.87% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Accrelist and its competitors. This is 43% below median its historical median of 1.52. According to the industry distribution chart, Accrelist ranks #382 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 57.4%.
Is Accrelist's FCF Margin % too high?
Accrelist's current FCF Margin % of 0.87% is 43% below median its 10-year median of 1.52. The Healthcare Providers & Services industry median FCF Margin % is 3.15. Accrelist's value of 0.87% is 72.4% below this industry median. Based on the distribution chart, Accrelist ranks #382 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Accrelist's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Accrelist ranks #382 out of 665 companies for FCF Margin %. This places Accrelist in the lower half of its industry. The industry median FCF Margin % is 3.15. Accrelist's value of 0.87% is 72.4% below this benchmark. While the company's 10-year median is 1.52 vs. the industry median of 3.15, Accrelist has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.15, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accrelist's current FCF Margin % of 0.87% is 72.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Accrelist and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accrelist's current FCF Margin % is 0.87%, which is 43% below median its own 10-year median of 1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accrelist stock overvalued right now?
Based on GuruFocus' analysis, Accrelist (SGX:QZG) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.04, compared to a current price of S$0.07 — trading 72.5% above its estimated fair value. The current FCF Margin % is 0.87%, which is 43% below median its 10-year median of 1.52 and 72.4% below the Healthcare Providers & Services industry median of 3.15. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Accrelist (SGX:QZG), the current FCF Margin % is 0.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accrelist Ltd is focused on the distribution of electronics components, plastic injection molding, mold design, and fabrication services. The company's segment comprises a Mechanical business unit (MBU), Aesthetic Medical Services (AMS), and others. Accrelist is focused on maintaining a diversified customer mix and product portfolio for MBU and EBU while continuing to expand upon the medical aesthetic products and services provided to consumers. it generates a vast majority of revenue from the MBU segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:QZG has been successfully added to your 
